NextPoint Therapeutics raises $80 million in Series B financing permitted to view these materials, please exit this webpage. Innovations, Redefining Our Team - Orna Therapeutics Bayer is committed to driving sustainable development and generating a positive impact with its businesses. Bayer Athletes, Disabled Stockholders' Meeting, Notice & Impact, Benefits Third parties that help us administer and manage our Services, including third parties that help us manage our communications, complete transactions, assist with our information technology and security programs, our lawyers, accountants, auditors, or regulatory bodies or other third parties as may be required by law. and Follow-up Questions, How to Life & Challenges, Reputation NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. This website is intended to provide information to an international audience outside the USA and UK. We may use Personal Data for a variety of different purposes as set out in further detail below. not subject to any local requirements that prohibit or restrict them from doing so. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. Protection, Environmental Republic, Dominican Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . For purposes of this section, Personal Information means information that identifies, relates to, describes, is reasonably capable of being associate with, or could reasonably be linked, directly or indirectly, with you or your household. About Leaps by BayerLeaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Bayers leadership in agriculture provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy. NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. In other Dr. Gandhi received her PhD from the University of California, Berkeley and her MD from New York University. Furthermore, where permissible, we may charge for this service. Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). The final prospectus, when published, will be Management, Supervisory NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. ProBioGen Executes a Master Service Agreement with NextPoint Career, Your Up and down the ladder: The latest comings and goings 14 new chief medical officers in February In relation to each member state of the European Economic Area which has implemented the Directive Stock Market | Financial News | myMotherLode.com There will be no public In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. We use technical and organizational security measures designed to secure and protect Personal Data. The financing will be used to advance NextPoint . For information on how to disable cookies, refer to your browsers documentation or documentation specific to certain types of cookies (for example Flash cookies and HTML5 cookies). NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Position, Position For more information, go to www.bayer.com. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Neither this announcement nor anything contained KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Apellis' blindness drug approved by FDA; Moderna strikes gene-editing And here is our regular feature in which we highlight a different person each week. us, How The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. INFORMATION FROM CHILDREN UNDER 13 YEARS OF AGE. the Market, Pharmaceutical Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. our employees, International We provide these links merely for your convenience. whatsoever in Africa, Sri NextPoint - MPM Capital & Medical Devices, Crop be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together Nextpoint, the industry-leader in cloud-based eDiscovery and Litigation support software, has secured $4.5 million in non-dilutive, growth capital. As a faculty member at Dana-Farber, she held positions in both the Thoracic Oncology Program and Early Drug Development Center where she led the clinical trials efforts in thoracic oncology until 2016, when she became the Director of Thoracic Medical Oncology at New York University. Contact Us - Nextpoint Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. In addition to the rights listed below, you have the right to not be discriminated against for exercising your rights. offer of the securities in any jurisdiction. Any person who is not a relevant person should not act or rely on the Viewing the materials you seek to access may not be lawful in certain jurisdictions. The most recent version of the Privacy Notice is reflected by the version date located at the top of this Privacy Notice. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. Financial 8+ years experience in a clinical operations role in biopharmaceutical industry with at least 5 years direct experience running oncology Ph1 clinical trials. Future Leadership Program - Engineers, To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. Dr. Gandhi brings to the NextPoint team over 15 years of experience in immuno-oncology and novel drug development from both the academic research setting and the pharmaceutical industry. NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno Bayer, Research and Bayer and the opportunities available. . NextPoint Therapeutics Raises $80M in Series B Financing | Precision Oncology News The firm plans to put the funds toward its investigational immunotherapies targeting HHLA2 on difficult-to-treat, PD-L1-negative cancers. Global Product Strategy, Position About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. any facility of a national securities exchange of the United States and the tender offer cannot be for Prescription Medicine in Europe, Counterfeits in This can include cookies, web beacons and similar technologies as described above. & Rewards, Values Use, Privacy The Site uses cookies and similar technologies to improve user experience, for performance and analytics, and to improve our content, products, and services. The candidate will collaborate with Research and Clinical Development to develop and refine NextPoints clinical translational strategy and drive its effective implementation to support our clinical programs. The Bayer brand stands for trust, reliability and quality throughout the world. For the purposes of this provision, the expression an offer to the public in relation to any Protection Products & Seeds, Supplier The investment portfolio includes more than 50 companies. Find out more: This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. We will respond to reasonable requests as soon as practicable and as required by law. available in electronic format on this webpage does not constitute an offer to sell or the The securities are only available to, and any invitation, Requests may be made only once a year and are free of charge. Procurement Management Trainee Program, Bridging We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. You may only make a verifiable consumer request for access or data portability twice within a 12-month period. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. News, Conditions of

Powershell Command To Monitor Network Traffic, Ocala Homes For Rent By Owner, Articles N